Australia - Hospital Average Length of Stay for Malignant Neoplasm of Bladder
Since 2014, Australia Hospital Average Length of Stay for Malignant Neoplasm of Bladder decreased by 2.4% year on year. At 4.7 Days in 2019, the country was number 24 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Bladder. South Korea topped the ranking with 11.3 Days in 2019, stable compared to 2018. Iceland witnessed the best average annual growth at +6.9% per year, while Mexico recorded the worst performance at -5% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.70 |
| 2018 | 4.80 |
| 2017 | 4.80 |
| 2016 | 4.80 |
| 2015 | 5.00 |
Download all data from 1993 to 2019
How does Australia rank in Hospital Average Length of Stay for Malignant Neoplasm of Bladder?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
11.30 | 2019 | +0.0 % | +0.7 % | View data | |
| 2 |
#2
Iceland
|
8.50 | 2019 | +2.4 % | +6.9 % | View data | |
| 23 |
#23
New Zealand
|
4.80 | 2019 | -2.0 % | -3.0 % | View data | |
| 24 |
#24
Australia
|
4.70 | 2019 | -2.1 % | -2.4 % | View data | |
| 24 |
#24
Turkey
|
4.70 | 2019 | +2.2 % | +1.3 % | View data | |